This effect might alleviate the ventricular arrhythmias in gain-of-function SCN5A variant carriers, but can controversially provoke arrhythmias and cause or worsen cardiac conduction delays at different levels in those with loss-of-function variants. This evidence concerns the gene SCN5A and cardiac arrhythmia.